Have a feature idea you'd love to see implemented?
Let us know!
EDSA Edesa Biotech Inc
Price (delayed)
$3.76
Market cap
$12.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.19
Enterprise value
$10.21M
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05
Highlights
EDSA's debt has dropped by 66% year-on-year and by 33% since the previous quarter
Edesa Biotech's EPS has increased by 37% YoY and by 7% from the previous quarter
The quick ratio has shrunk by 74% YoY and by 40% QoQ
The equity has dropped by 63% year-on-year and by 34% since the previous quarter
Key stats
What are the main financial stats of EDSA
Market
Valuations
Earnings
Shares outstanding
3.25M
Market cap
$12.21M
Enterprise value
$10.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.22
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$6.93M
EBITDA
-$6.74M
Free cash flow
-$5.39M
Per share
Balance sheet
Liquidity
EPS
-$2.19
Free cash flow per share
-$1.67
Book value per share
$0.89
Revenue per share
$0
TBVPS
$0.97
Total assets
$5.23M
Total liabilities
$2.36M
Debt
$38,817
Equity
$2.87M
Working capital
$686,007
Debt to equity
0.01
Current ratio
1.29
Quick ratio
1.1
Net debt/EBITDA
0.3
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-97.5%
Return on equity
-138%
Return on invested capital
N/A
Return on capital employed
-241.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EDSA stock price
How has the Edesa Biotech stock price performed over time
Intraday
0%
1 week
-7.62%
1 month
-15.12%
1 year
12.57%
YTD
-17.72%
QTD
-15.51%
Financial performance
How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.38M
Net income
-$6.93M
Gross margin
N/A
Net margin
N/A
EDSA's net income is up by 27% year-on-year and by 4.4% since the previous quarter
Edesa Biotech's operating income has increased by 14% YoY
Growth
What is Edesa Biotech's growth rate over time
Valuation
What is Edesa Biotech stock price valuation
P/E
N/A
P/B
4.22
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has increased by 37% YoY and by 7% from the previous quarter
The equity has dropped by 63% year-on-year and by 34% since the previous quarter
EDSA's price to book (P/B) is 36% higher than its last 4 quarters average of 3.1 but 4.1% lower than its 5-year quarterly average of 4.4
Efficiency
How efficient is Edesa Biotech business performance
The company's return on equity fell by 33% YoY and by 19% QoQ
Edesa Biotech's return on assets has decreased by 12% YoY and by 10% QoQ
Dividends
What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EDSA.
Financial health
How did Edesa Biotech financials performed over time
Edesa Biotech's total assets is 121% more than its total liabilities
The quick ratio has shrunk by 74% YoY and by 40% QoQ
EDSA's current ratio has shrunk by 71% YoY and by 35% QoQ
EDSA's debt is 99% smaller than its equity
EDSA's debt has dropped by 66% year-on-year and by 33% since the previous quarter
The equity has dropped by 63% year-on-year and by 34% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.